Paper36152307
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance.
Pichet Binette A and 9 others. Alzheimers Dement, 2023. Cited by 202 papers, by iCite.
Cite this record
ConductScience Library. Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance. Papers, record 36152307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36152307
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Humans | |
| Creatinine | |
| tau Proteins | |
| Amyloid beta-Peptides | |
| Biomarkers |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AG068398 | NIA NIH HHS | United States | R01AG068398 | PubMed and NIH | NIH RePORTER |
| RF1 AG061900 | NIA NIH HHS | United States | RF1AG061900 | PubMed and NIH | NIH RePORTER |
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33430940 | Kidney function and dementia risk in community-dwelling older adults: the Shanghai Aging Study. | Alzheimers Res Ther | 2021 | https://conductscience.org/library/papers/33430940 | PubMed |
| 2 | 32722745 | Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. | JAMA | 2020 | https://conductscience.org/library/papers/32722745 | PubMed |
| 3 | 32123386 | Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. | Nat Med | 2020 | https://conductscience.org/library/papers/32123386 | PubMed |
| 4 | 34031605 | Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures. | Nat Med | 2021 | https://conductscience.org/library/papers/34031605 | PubMed |
| 5 | 1244564 | Prediction of creatinine clearance from serum creatinine. | Nephron | 1976 | https://conductscience.org/library/papers/1244564 | PubMed |
| 6 | 29420472 | High performance plasma amyloid-β biomarkers for Alzheimer's disease. | Nature | 2018 | https://conductscience.org/library/papers/29420472 | PubMed |
| 7 | 26870824 | Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study. | EBioMedicine | 2016 | https://conductscience.org/library/papers/26870824 | PubMed |
| 8 | 31893563 | Confounding effect of blood volume and body mass index on blood neurofilament light chain levels. | Ann Clin Transl Neurol | 2020 | https://conductscience.org/library/papers/31893563 | PubMed |
| 9 | 31371569 | High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis. | Neurology | 2019 | https://conductscience.org/library/papers/31371569 | PubMed |
| 10 | 34021943 | Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease. | J Intern Med | 2021 | https://conductscience.org/library/papers/34021943 | PubMed |
| 11 | 34083813 | Biomarkers for neurodegenerative diseases. | Nat Med | 2021 | https://conductscience.org/library/papers/34083813 | PubMed |
| 12 | 29653606 | NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. | Alzheimers Dement | 2018 | https://conductscience.org/library/papers/29653606 | PubMed |
| 13 | 34542571 | Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease. | JAMA Neurol | 2021 | https://conductscience.org/library/papers/34542571 | PubMed |
| 14 | 33046608 | Association of Enlarged Perivascular Spaces and Measures of Small Vessel and Alzheimer Disease. | Neurology | 2021 | https://conductscience.org/library/papers/33046608 | PubMed |
| 15 | 29499171 | CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts. | Alzheimers Dement | 2018 | https://conductscience.org/library/papers/29499171 | PubMed |
| 16 | 33773595 | Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment. | Alzheimers Res Ther | 2021 | https://conductscience.org/library/papers/33773595 | PubMed |
| 17 | 33210117 | Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease. | Brain | 2020 | https://conductscience.org/library/papers/33210117 | PubMed |
| 18 | 28179466 | Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder. | Neurology | 2017 | https://conductscience.org/library/papers/28179466 | PubMed |
| 19 | 31009028 | Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. | JAMA Neurol | 2019 | https://conductscience.org/library/papers/31009028 | PubMed |
| 20 | 34897094 | Late-Life Obesity Associated with Tau Pathology in Cognitively Normal Individuals: The CABLE Study. | J Alzheimers Dis | 2022 | https://conductscience.org/library/papers/34897094 | PubMed |
Cited by177
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 202 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947251 | Plasma β-synuclein associates with hippocampal synaptic density measured with [11C]UCB-J PET and plasma tau markers in Alzheimer's disease. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42947251 | PubMed |
| 42940213 | Paired CSF-Plasma Analyte Signal Contrasts Across Alzheimer's Disease Clinical Stages and MCI-to-Dementia Conversion. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940213 | PubMed |
| 42902436 | Direction-specific biomarker profiles and clinical significance of plasma p-tau217/amyloid PET discordance in cognitively normal adults. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42902436 | PubMed |
| 42890575 | Early neuro biomarker changes and electrophysiological nerve dysfunction in Swedish V50M hereditary transthyretin amyloidosis: a pilot study. | Front Neurol | 2026 | https://conductscience.org/library/papers/42890575 | PubMed |
| 42880054 | Updated Italian intersocietal recommendations for the appropriate use of anti-amyloid monoclonal antibodies in Alzheimer's disease. | J Prev Alzheimers Dis | 2026 | https://conductscience.org/library/papers/42880054 | PubMed |
| 42865723 | Plasma biomarker strategies to reduce diagnostic uncertainty in p-tau217-based assessment of CSF amyloid positivity in secondary-care patients with MCI. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42865723 | PubMed |
| 42795418 | Comparative Analysis of Plasma Biomarkers of Alzheimer's Disease and Frontotemporal Dementia: The Dual Role of Soluble Fractalkine as a Biomarker of Frontotemporal Dementia and Its Neuroprotective Effects in Cortical Neurons "In Vitro". | Life (Basel) | 2026 | https://conductscience.org/library/papers/42795418 | PubMed |
| 42733904 | Health-related factors and their impact on blood-based biomarkers of Alzheimer's disease. | Aging Brain | 2026 | https://conductscience.org/library/papers/42733904 | PubMed |
| 42619275 | Prospective study on physical activity and Alzheimer's disease-related biomarkers. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42619275 | PubMed |
| 42558640 | Type 1 diabetes is associated with higher plasma levels of biomarkers of neurodegeneration and neuroinflammation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42558640 | PubMed |
| 42534839 | Anemia, iron deficiency, and blood biomarkers for Alzheimer disease: clinical interpretation and dementia risk stratification. | Front Nutr | 2026 | https://conductscience.org/library/papers/42534839 | PubMed |
| 42463545 | Predictive value of plasma p-tau217 for Alzheimer's dementia compared to other blood-based biomarkers. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42463545 | PubMed |
| 42450256 | Peripheral and Central miRNA Signatures in Alzheimer's Disease: Tissue-Specific Variability, Sex-Associated Differences, and Implications for Blood-Based Biomarkers. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450256 | PubMed |
| 42396324 | Reliable quantification of renal function from frozen blood samples. | medRxiv | 2026 | https://conductscience.org/library/papers/42396324 | PubMed |
| 42348024 | Head-to-head comparison of neurodegeneration biomarkers across two analytical platforms in Alzheimer's disease. | Aging Clin Exp Res | 2026 | https://conductscience.org/library/papers/42348024 | PubMed |
| 42273887 | Plasma p-tau markers, vascular factors, and cognitive decline in the CIMA-Q cohort. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42273887 | PubMed |
| 42255964 | Real-world use of lecanemab: patient pathway findings from a US multicenter study. | Alzheimers Dement (Amst) | 2026 | https://conductscience.org/library/papers/42255964 | PubMed |
| 42194093 | Common Medical Comorbidities, Demographic Factors and Levels of Plasma Biomarkers of Alzheimer's Disease and Neurodegeneration in Black/African American Older Adults. | Biomolecules | 2026 | https://conductscience.org/library/papers/42194093 | PubMed |
| 42188786 | Bacillus Calmette-Guérin (BCG) Vaccination and the Immune-Brain Axis: Implications for Neuroprotection and Neurodegenerative Disease. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42188786 | PubMed |
| 42169160 | Longitudinal plasma p-tau217 as a marker for tracking progression and predicting cognitive decline in Alzheimer's disease. | Alzheimers Res Ther | 2026 | https://conductscience.org/library/papers/42169160 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| CST3 | 1471 | PubTator's text mining | https://conductscience.org/library/genes/1471 | NCBI Gene |
| GFAP | 2670 | PubTator's text mining | https://conductscience.org/library/genes/2670 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| NEFL | 4747 | PubTator's text mining | https://conductscience.org/library/genes/4747 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36152307
GET https://conductscience.org/api/papers/v1/36152307/references?page=2